Vanda Pharmaceuticals Inc. Intellectual Property Contracts & Agreements
11 Contracts & Agreements
- License Agreements (11 contracts)
- License Agreement, dated January 13, 2022, by and among MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, Impax Laboratories LLC and the registrant (Filed With SEC on May 6, 2022)
- CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT (Filed With SEC on February 17, 2017)
- CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT (Filed With SEC on February 17, 2017)
- TENTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 29, 2013)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between ELI LILLY AND COMPANY (an Indiana corporation) and VANDA PHARMACEUTICALS INC. (a Delaware corporation) Dated as... (Filed With SEC on August 3, 2012)
- NINTH AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 30, 2012)
- AMENDMENT TO AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 19, 2010)
- EX-10.4: NDD-094 LICENSE AGREEMENT (Filed With SEC on April 7, 2006)
- EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on April 7, 2006)
- EX-10.4: NDD-094 LICENSE AGREEMENT (Filed With SEC on February 16, 2006)
- EX-10.3: AMENDED AND RESTATED LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on February 16, 2006)
